Skip to content

Comparison Ulcertec with Ulcertec AG

Comparison Ulcertec with Ulcertec AG

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029690
Enrollment
18
Registered
2023-01-30
Start date
2022-10-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I87.2 I83.2

Interventions

Group 1: All patients who are suitable for the study after checking the inclusion and exclusion criteria take part. The study participants wear both compression stockings to be compared one after the

Sponsors

Bauerfeind AG - Phlebology Business Development & Medical Affairs
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients between 18 and 85 years CVI in stage according to CEAP C5 and C6

Exclusion criteria

Exclusion criteria: Known contraindications to wearing the compression stocking (e.g. intolerance to the compression material advanced heart failure)

Design outcomes

Primary

MeasureTime frame
Lower leg volume measured at the beginning and end of the wearing phases using 3D-assisted volume reconstruction of the legs (BT 610)

Secondary

MeasureTime frame
Before and after each wearing phase, the following data are collected: 1. wearing comfort (questionnaire) 2. volume change of the thigh (BT 610) 3. frequency of adverse events (questionnaire) 4. quality of life (SF36, Tübingen Quality of Life Questionnaire, DLQI)

Countries

Germany

Contacts

Public ContactMichael Jünger

Klinik und Poliklinik für Hautkrankheiten der Universität Greifswald

juenger@uni-greifswald.de03834/866770

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026